I believe GC pivoted...Lympro progressing nicely...but he did say"MSPrecise is our lead commercial diagnostic via CLIA in 2015"...Lympro being a close second due to new significant biomarker added for MV data for CLIA....just a little bit longer and we'll be there.

mosserman